SCHEMBL22309261

SCHEMBL22309261

c1ccc(-c2nc(-c3cccc(-c4cccc(-c5nc(-c6ccccc6)nc(-c6ccccc6)n5)c4)c3)cc(-c3cccc(-c4ccc5c(c4)c4ccccc4n5-c4ccccc4)c3)n2)cc1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.46
ATM Q13315 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.46
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
ALDH1A1 P00352 3/20 0.45
MAPT P10636 3/20 0.45
HPGD P15428 3/20 0.45
LMNA P02545 2/20 0.45
GLA P06280 1/20 0.45
NTSR1 P30989 1/20 0.40
PTGER4 P35408 1/20 0.40
PTGES O14684 1/20 0.35
MAOB P27338 2/20 0.35
MAOA P21397 1/20 0.35
NPY5R Q15761 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA1 P30542 1/20 0.35
IL1R1 P14778 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22113749 1.00 KDM4E (0.46) KDM4EATML3MBTL1KMT2AMEN1
SCHEMBL22309260 0.99 MEN1 (0.47) KDM4EATML3MBTL1KMT2AMEN1
SCHEMBL22308770 0.99 MEN1 (0.47) KDM4EATML3MBTL1KMT2AMEN1
SCHEMBL22309214 0.99 MEN1 (0.47) KDM4EATML3MBTL1KMT2AMEN1
SCHEMBL22308702 0.99 MEN1 (0.47) KDM4EATML3MBTL1KMT2AMEN1
SCHEMBL22074532 0.97 MEN1 (0.46) KDM4EATML3MBTL1KMT2AMEN1
SCHEMBL22074527 0.96 MEN1 (0.46) KDM4EATML3MBTL1KMT2AMEN1
SCHEMBL15394863 0.95 KDM4E (0.46) KDM4EATML3MBTL1KMT2AMEN1
SCHEMBL15257551 0.95 KDM4E (0.49) KDM4EATML3MBTL1KMT2AMEN1
SCHEMBL14426110 0.95 MEN1 (0.50) KDM4EATML3MBTL1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 US disclosed
US-11917910-B2 Organic compound and organic electroluminescent device using the same SOLUS ADVANCED MATERIALS CO., LTD. (KR) 2024-02-27 US disclosed
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOOSAN CORPORATION (KR) 2020-08-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200251659-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME VDAC1, OR10J3, PIEZO1 KDM4E 1358/4885ATM 3736/4885L3MBTL1 355/4885
US-11917910-B2 Organic compound and organic electroluminescent device using the same VDAC1, OR10J3, PIEZO1 KDM4E 1358/4885ATM 3736/4885L3MBTL1 355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.